Clinical results of microwave regional coagulation therapy on bladder cancer
スポンサーリンク
概要
- 論文の詳細を見る
Between April 1985 and June 1993, 124 consecutive patients with urinary bladder carcinoma underwent transurethral microwave regional coagulation therapy (MRC). Of these patients, 108 had neither lymphnode metastasis nor distant metastases. We investigated the survival rate and the prognostic significance in the 108 patients. We also performed intracavitary irradiation in patients who had been suffered frequent recurrences. The prognosis of 79 patients with superficial tumor (Ta, Ti, NOMO) and that of 29 patients with muscle infiltrating tumor (T2, T3, NOMO) resulted in the survival rate of 80.7% and 69.0% after 5 years, respectively. The death rate of patients with high grade tumor (G3) was significantly higher than those with G1 and G2 tumors. With MRC the preservation rate of the urinary bladder was 66% in the patients with muscle-infiltrating tumors.<BR>In conclusions, these results indicate that we might be able to treat the invasive urinary bladder cancer by MRC without lymphnodes nor distant metastases as well as superficial cancer.
- 特定非営利活動法人 Microwave Surgery研究会の論文
特定非営利活動法人 Microwave Surgery研究会 | 論文
- Microwave Surgeryの新たなる飛翔─マイクロ波を用いた手術デバイスの開発と実用化─
- 肝細胞癌に対する局所療法の予後に関する検討
- 肝細胞癌治療における経皮的マイクロ波凝固療法の意義
- 肝細胞癌に対する経皮的マイクロ波凝固療法の治療成績―肝切除および経皮的エタノール注入療法との比較―
- 婦人科領域における内視鏡下治療